Biomira reports higher revenues:
This article was originally published in Clinica
Executive Summary
Canadian developer of cancer diagnostics and therapeutics Biomira increased its 1995 sales to Can$7.7 million ($5.6 million), up 11% on the year. Its net loss increased to Can$21.4 million from Can$17.0 million.